FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Misses …

May 6, 2024 · Foghorn Therapeutics (NASDAQ: FHTX) just reported results for the first quarter of 2024. Foghorn Therapeutics reported earnings per share of -59 cents. This was above the analyst estimate for EPS ...

19%
OFF

Foghorn Therapeutics Inc. (FHTX) Reports Q3 Loss, Misses …

1 week from now

Nov 4, 2024 · Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of 26.19% and 3.27%, respectively, for the quarter ended September 2024. Do the numbers hold clues to …

yahoo.com

$19
OFF

Foghorn Therapeutics (FHTX) Collaborates With Eli Lilly And

1 week from now

The net loss increased to $19.1 million in Q3 2024 from $14.3 million in Q3 2023, despite which GAAP earnings per share (EPS) of -$1.18 missed expectations by $0.24.Foghorn had a solid …

nasdaq.com

$0.34
OFF

Foghorn Therapeutics Inc. (FHTX) Latest Stock News - Seeking Alpha

1 week from now

4 days ago · Get the latest news and real-time alerts from Foghorn Therapeutics Inc. (FHTX) stock at Seeking Alpha. ... Foghorn Therapeutics GAAP EPS of $0.34 beats by $1.09, revenue …

seekingalpha.com

1%
OFF

Foghorn Therapeutics Past Earnings Performance - Simply Wall St

1 week from now

Foghorn Therapeutics's earnings have been declining at an average annual rate of -11.1%, while the Biotechs industry saw earnings growing at 19.3% annually. ... Foghorn Therapeutics …

simplywall.st

6%
OFF

Foghorn Therapeutics (FHTX) Upgraded To Strong Buy: Here's …

1 week from now

Earnings Estimate Revisions for Foghorn Therapeutics. For the fiscal year ending December 2024, this company is expected to earn -$1.53 per share, which is a change of 34.6% from the …

msn.com

05%
OFF

Foghorn Therapeutics (FHTX) Loses -23.05% In 4 Weeks, Here's …

1 week from now

2 days ago · Foghorn Therapeutics Inc. (FHTX Quick Quote FHTX - Free Report) has been beaten down lately with too much selling pressure. While the stock has lost 23.1% over the …

zacks.com

FAQs about FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Misses … Coupon?

What is the consensus EPS estimate for Foghorn Therapeutics (fhtx)?

The current consensus EPS estimate is -$0.46 on $11.3 million in revenues for the coming quarter and -$1.88 on $31.3 million in revenues for the current fiscal year. Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of 26.19% and 3.27%, respectively, for the quarter ended September 2024. ...

How much does Foghorn Therapeutics (fhtx) earn?

Foghorn Therapeutics (NASDAQ:FHTX) has a recorded net income of -$108.88 million. FHTX has generated -$2.74 earnings per share over the last four quarters. What is Foghorn Therapeutics's EPS forecast for next year? Foghorn Therapeutics's earnings are expected to grow from ($2.81) per share to ($2.40) per share in the next year. ...

When is Foghorn Therapeutics's next earnings date?

Earnings for Foghorn Therapeutics are expected to grow in the coming year, from ($2.81) to ($2.40) per share. Foghorn Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 14th, 2023 based off prior year's report dates. When is Foghorn Therapeutics's earnings date? ...

What was Foghorn Therapeutics' stock price on January 1st 2025?

Foghorn Therapeutics' stock was trading at $4.72 on January 1st, 2025. Since then, FHTX shares have increased by 1.7% and is now trading at $4.80. How were Foghorn Therapeutics' earnings last quarter? Foghorn Therapeutics Inc. (NASDAQ:FHTX) announced its quarterly earnings results on Thursday, August, 8th. ...

Where can I buy fhtx stock?

Shares of FHTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Foghorn Therapeutics own? ...

How sustainable is Foghorn Therapeutics (Foghorn) stock?

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Foghorn Therapeutics shares have added about 28.7% since the beginning of the year versus the S&P 500's gain of 20.1%. ...